Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 4/20 | 1.00 |
| ▸ | CA1 | P00915 | 4/20 | 1.00 |
| ▸ | MGLL | Q99685 | 3/20 | 1.00 |
| ▸ | ENPP2 | Q13822 | 3/20 | 0.68 |
| ▸ | CA4 | P22748 | 1/20 | 0.68 |
| ▸ | CA6 | P23280 | 1/20 | 0.68 |
| ▸ | CA5A | P35218 | 1/20 | 0.68 |
| ▸ | CA7 | P43166 | 1/20 | 0.68 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.68 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.68 |
| ▸ | TRPV1 | Q8NER1 | 3/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | MMP3 | P08254 | 1/20 | 0.50 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | LPL | P06858 | 1/20 | 0.48 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Biphenylboronic Acid SCHEMBL129728 | 1.00 | CA2 (1.00) | CA2CA1MGLLENPP2CA4 | |
| SCHEMBL12860012 | 1.00 | CA2 (1.00) | CA2CA1MGLLENPP2CA4 | |
| Biphenylboronic Acid SCHEMBL14692394 | 0.95 | CA2 (0.90) | CA2CA1MGLLENPP2CA4 | |
| SCHEMBL16657334 | 0.93 | CA1 (0.86) | CA2CA1MGLLENPP2CA4 | |
| Biphenyl SCHEMBL796676 | 0.92 | CA1 (0.84) | CA2CA1MGLLENPP2CA4 | |
| SCHEMBL29071488 | 0.91 | MGLL (0.82) | CA2CA1MGLLENPP2CA4 | |
| SCHEMBL30445177 | 0.91 | CA1 (0.82) | CA2CA1MGLLENPP2CA4 | |
| SCHEMBL20955795 | 0.91 | CA1 (0.82) | CA2CA1MGLLENPP2CA4 | |
| SCHEMBL20955808 | 0.91 | CA1 (0.82) | CA2CA1MGLLENPP2CA4 | |
| SCHEMBL12419993 | 0.91 | CA1 (0.82) | CA2CA1MGLLENPP2CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230150982-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, MANUFACTURING METHOD THEREFOR, AND COMPOSITION FOR ORGANIC LAYER | LT MATERIALS CO., LTD. (KR) | 2023-05-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230150982-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, MANUFACTURING METHOD THEREFOR, AND COMPOSITION FOR ORGANIC LAYER | CYP1B1, NOTUM, ORMDL3 | CA2 4411/4885CA1 3041/4885MGLL 1152/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.